Human Liver Model Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Human Liver Model Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The human liver model market size has seen swift expansion in recent years. It is anticipated to increase from $2.34 billion in 2024 to $2.62 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.9%. The historical growth of this market can be ascribed to necessities in drug development, breakthroughs in biotechnology, alternatives to animal testing, the rise in liver diseases, and regulatory requirements.

The human liver model market size is poised for rapid growth over the next few years. It is forecast to expand to $4.39 billion by 2029, achieving a compound annual growth rate (CAGR) of 13.7%. This growth during the forecast period is attributable to ai and machine learning integration, patient-derived liver models, bioengineering breakthroughs, drug safety and toxicity testing requirements, and virtual clinical trials. Key trends expected in the forecast period encompass multi-organ models integration, 3d bioprinting innovations, high-throughput screening capability, enhanced vascularization and blood flow, and ethical and regulatory compliance.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12244&type=smp

Which Drivers Are Supporting Growth Of The Human Liver Model Market?

An increase in liver disease cases is anticipated to drive the expansion of the human liver model market in the future. Liver disease encompasses any condition of the liver that can impede its proper function. The application of human liver models represents a growing research field with the capacity to enhance comprehension of liver ailments and advance drug development. Consequently, the increasing prevalence of liver diseases is fostering the growth of the human liver model market. For example, in September 2022, Caner Australia, a governmental cancer agency based in Australia, reported approximately 2,905 new cases of liver cancer diagnosed in Australia in 2022, comprising 2,113 males and 792 females. Additionally, the likelihood of developing liver cancer by age 85 is projected at 1 in 103 (or 0.97%) in 2022, specifically 1 in 70, or 1.4%, for men, and 1 in 195, or 0.51%, for women. Thus, the escalating incidence of liver disease is indeed fueling the human liver model market.

What Are The Different Segment Classifications Within The Human Liver Model Market?

The human liver modelmarket covered in this report is segmented –

1) By Product: Liver Organoids; Liver-On-A-Chip; 2D Models; Animal Models; 3D Bioprinting

2) By Application: Educational; Drug Discovery; Other Applications

3) By End Users: Research Institutes; Pharmaceutical Companies; Other End Users

Subsegments:

1) By Liver Organoids: Primary Liver Organoids; Induced Pluripotent Stem Cell (iPSC)-Derived Organoids

2) By Liver-On-A-Chip: Microfluidic Liver Chips; Multi-Organ Chip Systems

3) By 2D Models: Liver Cell Cultures; Liver Cell Lines

4) By Animal Models: Rodent Models; Large Animal Models

5) By 3D Bioprinting: Bioprinted Liver Tissues; Hybrid Bioprinted Models

What Trends Are Expected To Drive The Human Liver Model Market?

Product innovation has emerged as a key trend gaining traction in the human liver model market. Major companies operating within the human liver model market are focusing on creating advanced products to strengthen their position. For example, in April 2023, LifeNet Health Life Sciences, a US-based provider of human cell and tissue-based solutions, launched TruVivo, a pioneering liver system made entirely of human cells, which will support critical research and development of new drugs and compounds. This innovative 2D+ solution merges the robust data characteristic of 3D models with the flexibility and ease of a 2D model.

Which Major Industry Participants Are Leading The Human Liver Model Market Growth?

Major companies operating in the human liver model market include Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, Ascendance Biotechnology Inc., HemoShear Therapeutics Inc., Cyfuse Biomedical, MIMETAS BV, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaïon SA.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Human Liver Model Market?

North America was the largest region in the human liver model market in 2024. The regions covered in the human liver model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Human Liver Model Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12244&type=smp

Browse Through More Reports Similar to the Global Human Liver Model Market 2025, By The Business Research Company

Measuring And Control Instruments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/measuring-and-control-instruments-global-market-report

Watch Clock Measuring Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/watch-clock-measuring-device-global-market-report

Navigational Measuring Electro Medical And Control Instruments Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/navigational-measuring-electro-medical-and-control-instruments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795